BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) is associated with tobacco use. Still, most smokers do not develop HNSCC. The mechanisms of varying susceptibility to HNSCC are poorly studied to date. Tobacco metabolite research provides insight regarding the innate metabolism and excretion of carcinogens. METHODS: Smokers with HNSCC (cases) were compared with smokers without HNSCC (controls) in a matched cohort. The tobacco metabolites studied were: 1-hydroxypyrene (1-HOP), N'-nitrosonornicotine (NNN), and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL). RESULTS: In 33 subjects, mean 1-HOP was 1.82 pmol/mg creatinine versus 1.08 pmol/mg creatinine (p = .004) and mean NNN was 0.10 pmol/mg creatinine versus 0.04 pmol/mg creatinine (p = .01) in cases and controls, respectively. NNAL did not differ between groups. CONCLUSIONS: Smokers with HNSCC have elevated urinary levels of 1-HOP and total NNN compared with matched controls, suggesting an increased effective exposure to these carcinogens. Tobacco constituent metabolites may be useful in understanding tobacco-related carcinogenesis in HNSCC.
BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) is associated with tobacco use. Still, most smokers do not develop HNSCC. The mechanisms of varying susceptibility to HNSCC are poorly studied to date. Tobacco metabolite research provides insight regarding the innate metabolism and excretion of carcinogens. METHODS: Smokers with HNSCC (cases) were compared with smokers without HNSCC (controls) in a matched cohort. The tobacco metabolites studied were: 1-hydroxypyrene (1-HOP), N'-nitrosonornicotine (NNN), and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL). RESULTS: In 33 subjects, mean 1-HOP was 1.82 pmol/mg creatinine versus 1.08 pmol/mg creatinine (p = .004) and mean NNN was 0.10 pmol/mg creatinine versus 0.04 pmol/mg creatinine (p = .01) in cases and controls, respectively. NNAL did not differ between groups. CONCLUSIONS: Smokers with HNSCC have elevated urinary levels of 1-HOP and total NNN compared with matched controls, suggesting an increased effective exposure to these carcinogens. Tobacco constituent metabolites may be useful in understanding tobacco-related carcinogenesis in HNSCC.
Authors: J Bradley Hochalter; Yan Zhong; Shaomei Han; Steven G Carmella; Stephen S Hecht Journal: Chem Res Toxicol Date: 2011-01-13 Impact factor: 3.739
Authors: A K Alexandrie; M Warholm; U Carstensen; A Axmon; L Hagmar; J O Levin; C Ostman; A Rannug Journal: Carcinogenesis Date: 2000-04 Impact factor: 4.944
Authors: Ahmedin Jemal; Taylor Murray; Alicia Samuels; Asma Ghafoor; Elizabeth Ward; Michael J Thun Journal: CA Cancer J Clin Date: 2003 Jan-Feb Impact factor: 508.702
Authors: Samir S Khariwala; Steven G Carmella; Irina Stepanov; Dipankar Bandyopadhyay; Heather H Nelson; Bevan Yueh; Dorothy K Hatsukami; Stephen S Hecht Journal: Laryngoscope Date: 2015-04-15 Impact factor: 3.325
Authors: Bin Ma; Chris Ruszczak; Vipin Jain; Samir S Khariwala; Bruce Lindgren; Dorothy K Hatsukami; Irina Stepanov Journal: Chem Res Toxicol Date: 2016-10-12 Impact factor: 3.739
Authors: Samir S Khariwala; Bin Ma; Chris Ruszczak; Steven G Carmella; Bruce Lindgren; Dorothy K Hatsukami; Stephen S Hecht; Irina Stepanov Journal: Cancer Prev Res (Phila) Date: 2017-07-05
Authors: Marta Szukalska; Krzysztof Szyfter; Ewa Florek; Juan P Rodrigo; Alessandra Rinaldo; Antti A Mäkitie; Primož Strojan; Robert P Takes; Carlos Suárez; Nabil F Saba; Boudewijn J M Braakhuis; Alfio Ferlito Journal: Cancers (Basel) Date: 2020-11-05 Impact factor: 6.639